Showing 49–55 of 55 results

  • Novolog Flexpens

    Original price was: $140.99.Current price is: $130.99.

    Novolog Flexpens stands at the pinnacle of diabetes management tools, encapsulating years of research, feedback, and technological advancements. Each pen is prefilled with Insulin Aspart, a fast-acting insulin analog renowned for its ability to provide effective glycemic control promptly.

  • Prolia (Denosumab)

    Original price was: $1,634.54.Current price is: $1,624.54.

    Prolia® is a powerful tool in the battle against osteoporosis – a condition causing bones to weaken and become more susceptible to fractures. Factors like age, post-menopause (in women), family history of osteoporosis, and prolonged use of certain medications can elevate the risk of osteoporosis development.

  • Soliqua Solostar

    Original price was: $831.71.Current price is: $302.43.

    Soliqua Solostar Pens, infused with insulin glargine and lixisenatide, offer an advanced solution for adults battling type 2 diabetes mellitus. When paired with a balanced diet and consistent exercise, they optimize blood glucose control.

  • Toujeo

    Original price was: $350.16.Current price is: $140.00.

    Toujeo (Insulin Glargine) stands as an innovative long-acting insulin solution, available in a sterile subcutaneous injection formulation at a concentration of 300 units/mL. Crafted through advanced recombinant DNA technology from a non-pathogenic laboratory strain of Escherichia coli, Toujeo guarantees precision and reliability.

  • Toujeo Max

    Original price was: $512.61.Current price is: $510.61.

    Toujeo Max, a long-acting insulin formulated as a sterile solution for subcutaneous injection, boasting a concentration of 300 units/mL. Crafted through innovative recombinant DNA technology, Insulin Glargine originates from a non-pathogenic Escherichia coli laboratory strain.

  • Xiidra

    Original price was: $733.75.Current price is: $375.99.

    Xiidra recognized scientifically as a lifitegrast ophthalmic solution, is a pioneering medication specifically designed to combat the inflammation that contributes significantly to Dry Eye Disease. This novel product signifies a revolution in the field of ophthalmic solutions, being the first of its kind to address this specific underlying cause of Dry Eye Disease.

  • Xultophy Prefilled Pen 100mg/3.6ml 3ml 5 Pens

    Original price was: $1,427.12.Current price is: $489.00.

    Xultophy marries the benefits of Insulin Degludec, a long-acting basal insulin, with Liraglutide, a GLP-1 receptor agonist. Both active ingredients are derived using the recombinant DNA expression of Saccharomyces cerevisiae.